feed,title,long_url,short_url
Benzinga,"Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIOÂ® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy",https://www.benzinga.com/pressreleases/20/12/n18868687/antengene-announces-its-u-s-partner-karyopharm-therapeutics-inc-has-received-fda-approval-of-xpovi,https://j.mp/3h7I83C
